Among pediatric patients with congenital fibrinogen deficiency, the administration of human fibrinogen concentrate may be efficacious for on-demand treatment and surgical prophylaxis.
Among pediatric patients with cerebral venous thrombosis, treatment with rivaroxaban or standard anticoagulants resulted in a similarly reduced risk for recurrent VTE or bleeding.
Among patients receiving allogeneic stem cell transplantation, high levels of vitamin E may be linked to less acute graft-vs-host disease.
Experts assessed mortality rates linked to allogeneic stem cell transplantation in the past 40 years using data from the European Society for Blood and Marrow Transplantation registry.
Investigators reported the results of the phase 3 MAIA trial on HRQOL outcomes in patients with transplant-ineligible, newly diagnosed MM.
Investigators assessed the patterns in medication utilization among pediatric inpatients with cancer in their last week of life.
Investigators assessed the effectiveness of integrated palliative and oncology care on end-of-life outcomes in patients with acute myeloid leukemia.
Investigators aimed to understand how well adolescents with cancer understand their prognosis compared with their health care providers and caregivers.
Among patients with sickle cell disease, inhibition of BCL11A via gene knockdown is an effect target to induce fetal hemoglobin.
Patients with cancer, especially those of the African American population, who have COVID-19 infection are at a greater risk of hospitalization and death.
